- Home
- TARA vs LAW Comparison
TARA vs LAW Comparison
Compare TARA & LAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARA | LAW |
|---|---|---|
| Founded | N/A | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.8M | 274.2M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TARA | LAW |
|---|---|---|
| Price | $4.34 | $4.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $24.40 | $8.00 |
| AVG Volume (30 Days) | ★ 766.5K | 511.1K |
| Earning Date | 05-01-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | 22.58 |
| EPS | N/A | ★ N/A |
| Revenue | $2,948,000.00 | ★ $156,849,000.00 |
| Revenue This Year | N/A | $11.23 |
| Revenue Next Year | N/A | $10.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.29 |
| 52 Week Low | $2.77 | $2.45 |
| 52 Week High | $7.82 | $9.11 |
Technical Indicators
Market Signals| Indicator | TARA | LAW |
|---|---|---|
| Relative Strength Index (RSI) | 34.51 | 56.50 |
| Support Level | $4.21 | $3.34 |
| Resistance Level | $4.59 | $5.00 |
| Average True Range (ATR) | 0.30 | 0.25 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 4.29 | 77.35 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
About LAW CS Disco Inc.
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.